Anavex Life Sciences Corp (AVXL)
7.685
+0.40
(+5.42%)
USD |
NASDAQ |
Nov 05, 16:00
7.71
+0.02
(+0.33%)
After-Hours: 20:00
Anavex Life Sciences Price to Book Value: 5.021 for Nov. 5, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 4.763 |
| November 01, 2024 | 4.466 |
| October 31, 2024 | 4.325 |
| October 30, 2024 | 3.731 |
| October 29, 2024 | 3.734 |
| October 28, 2024 | 3.776 |
| October 25, 2024 | 3.424 |
| October 24, 2024 | 3.482 |
| October 23, 2024 | 3.522 |
| October 22, 2024 | 3.685 |
| October 21, 2024 | 3.561 |
| October 18, 2024 | 3.692 |
| October 17, 2024 | 3.597 |
| October 16, 2024 | 3.610 |
| October 15, 2024 | 3.522 |
| October 14, 2024 | 3.535 |
| October 11, 2024 | 3.515 |
| October 10, 2024 | 3.339 |
| October 09, 2024 | 3.352 |
| October 08, 2024 | 3.424 |
| October 07, 2024 | 3.509 |
| October 04, 2024 | 3.656 |
| October 03, 2024 | 3.659 |
| October 02, 2024 | 3.695 |
| October 01, 2024 | 3.554 |
| Date | Value |
|---|---|
| September 30, 2024 | 3.711 |
| September 27, 2024 | 3.711 |
| September 26, 2024 | 3.705 |
| September 25, 2024 | 3.561 |
| September 24, 2024 | 3.633 |
| September 23, 2024 | 3.587 |
| September 20, 2024 | 3.685 |
| September 19, 2024 | 3.763 |
| September 18, 2024 | 3.594 |
| September 17, 2024 | 3.567 |
| September 16, 2024 | 3.724 |
| September 13, 2024 | 3.469 |
| September 12, 2024 | 3.404 |
| September 11, 2024 | 3.352 |
| September 10, 2024 | 3.270 |
| September 09, 2024 | 3.365 |
| September 06, 2024 | 3.365 |
| September 05, 2024 | 3.633 |
| September 04, 2024 | 3.672 |
| September 03, 2024 | 3.567 |
| August 30, 2024 | 3.933 |
| August 29, 2024 | 3.901 |
| August 28, 2024 | 3.842 |
| August 27, 2024 | 3.972 |
| August 26, 2024 | 4.156 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.100
Minimum
Apr 25 2024
27.57
Maximum
Jun 28 2021
7.230
Average
6.088
Median
Price to Book Value Benchmarks
| Baxter International Inc | 2.409 |
| Bruker Corp | 5.189 |
| BioXcel Therapeutics Inc | -- |
| AdaptHealth Corp | 0.8299 |
| NovaBay Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| Price | 7.685 |
| Earnings Yield | -6.64% |
| Market Cap | 651.65M |